EVE – The Biofactory – is a spin-off of the Italian National Research Council (CNR) that created a pioneering platform for the production and engineering of Extracellular Vesicles (EVs) from a green, sustainable source: micro-algae. These EVs, which we have named algosomes, are produced through a scalable and GMP-compliant process, with the aim to develop new configurable therapeutic and cosmetic formulations.
Company Details
- Employees
- 2
- Address
- Via Giuseppe Mario Puglia, 21, Palermo,sicily 90134,italy
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.evebiofactory.com/
- Keywords
- Biotechnology and EVs.
- HQ
- Palermo, Sicily
- Competitors
- Arterra Bioscience S.p.A., HansaBioMed Life Sciences Ltd, International Society for Extracellular Vesicles, Resysten Italia, Student Network on EVs - SNEV, Exosomics SpA, ATen Center - Advanced Technologies Network Center, EVIta-Italian society for Extracellular vesicles, FoLIA, Vesiculab.
Eve Biofactory Questions
Eve Biofactory's website is https://www.evebiofactory.com/
Eve Biofactory's LinkedIn profile is https://it.linkedin.com/company/eve-biofactory
Eve Biofactory has
2 employees.
View email and phone details for 2
employees at Eve Biofactory.
Eve Biofactory's industry is
Biotechnology Research
Eve Biofactory's top competitors are
Arterra Bioscience S.p.a.,
Hansabiomed Life Sciences Ltd,
International Society For Extracellular Vesicles,
Resysten Italia,
Student Network On Evs - Snev,
Exosomics Spa,
Aten Center - Advanced Technologies Network Center,
Evita-Italian Society For Extracellular Vesicles,
Folia,
Vesiculab.
Eve Biofactory's categories are Biotechnology Research
